81 related articles for article (PubMed ID: 9499304)
1. [value of bone densitometry in pediatric renal transplantation].
Melgosa Hijosa M; Romero de Paz MD; García Meseguer MC; Alonso Melgar A; Coya J; Navarro M
An Esp Pediatr; 1997 Oct; 47(4):373-7. PubMed ID: 9499304
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral disorders in pediatric and adolescent renal transplant recipients.
Derakhshan A; Behbahan AG; Lotfi M; Omrani GH; Fallahzadeh MH; Basiratnia M; Al-Hashemi GH
Pediatr Transplant; 2011 Jun; 15(4):367-75. PubMed ID: 21429060
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.
Westeel FP; Mazouz H; Ezaitouni F; Hottelart C; Ivan C; Fardellone P; Brazier M; El Esper I; Petit J; Achard JM; Pruna A; Fournier A
Kidney Int; 2000 Oct; 58(4):1788-96. PubMed ID: 11012914
[TBL] [Abstract][Full Text] [Related]
4. Bone loss in pediatric renal transplant recipients.
el-Husseini AA; el-Agroudy AE; Sobh MA; Ghoneim MA
Nefrologia; 2003; 23 Suppl 2():131-4. PubMed ID: 12778870
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
Goffin E; Devogelaer JP; Lalaoui A; Depresseux G; De Naeyer P; Squifflet JP; Pirson Y; van Ypersele de Strihou C
Transpl Int; 2002 Mar; 15(2-3):73-80. PubMed ID: 11935163
[TBL] [Abstract][Full Text] [Related]
6. Bone histopathology and densitometry comparison between cyclosporine a monotherapy and prednisolone plus azathioprine dual immunosuppression in renal transplant patients.
Cueto-Manzano AM; Konel S; Crowley V; France MW; Freemont AJ; Adams JE; Mawer B; Gokal R; Hutchison AJ
Transplantation; 2003 Jun; 75(12):2053-8. PubMed ID: 12829911
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in pediatric patients after renal transplantation.
Behnke B; Altrogge H; Delling G; Kruse HP; Müller-Wiefel DE
Clin Nephrol; 1996 Jul; 46(1):24-9. PubMed ID: 8832146
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density changes within 11 months of renal transplantation in Iranian patients.
Bayat N; Einollahi B; Pourfarzian V; Alishiri G; Nemati E; Bagheri N; Miri SM; Elizeii PK
Transplant Proc; 2007 May; 39(4):1039-43. PubMed ID: 17524886
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone and bone mass after kidney transplantation.
Kusec V; Smalcelj R; Cvijetić S
Acta Med Croatica; 2002; 56(1):17-20. PubMed ID: 12455449
[TBL] [Abstract][Full Text] [Related]
10. Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation.
Dolgos S; Hartmann A; Bønsnes S; Ueland T; Isaksen GA; Godang K; Pfeffer P; Bollerslev J
Clin Transplant; 2008; 22(4):462-8. PubMed ID: 18318737
[TBL] [Abstract][Full Text] [Related]
11. Weekly risedronate in kidney transplant patients with osteopenia.
Torregrosa JV; Fuster D; Pedroso S; Diekmann F; Campistol JM; Rubí S; Oppenheimer F
Transpl Int; 2007 Aug; 20(8):708-11. PubMed ID: 17555530
[TBL] [Abstract][Full Text] [Related]
12. Rapid steroid discontinuation for pediatric renal transplantation: a single center experience.
Lau KK; Haddad MN; Berg GM; Perez RV; Butani L
Pediatr Transplant; 2007 Aug; 11(5):504-10. PubMed ID: 17631018
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of osteoporosis, osteopenia, and vertebral fractures in long-term renal transplant recipients.
Marcén R; Caballero C; Uriol O; Fernández A; Villafruela JJ; Pascual J; Martins J; Rodriguez N; Burgos FJ; Ortuño J
Transplant Proc; 2007 Sep; 39(7):2256-8. PubMed ID: 17889156
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
15. Areal and volumetric bone mineral density changes after renal transplantation in children: a longitudinal study.
Hamiwka LA; Hanna M; Midgley JP; Wade AW; Grisaru S
Transplant Proc; 2008 Jun; 40(5):1404-6. PubMed ID: 18589117
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density in pediatric transplant recipients.
Daniels MW; Wilson DM; Paguntalan HG; Hoffman AR; Bachrach LK
Transplantation; 2003 Aug; 76(4):673-8. PubMed ID: 12973107
[TBL] [Abstract][Full Text] [Related]
17. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients.
Herman M; Weinstein T; Korzets A; Chagnac A; Ori Y; Zevin D; Malachi T; Gafter U
J Lab Clin Med; 2001 Jan; 137(1):14-20. PubMed ID: 11150019
[TBL] [Abstract][Full Text] [Related]
18. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
[TBL] [Abstract][Full Text] [Related]
19. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
Fahrleitner A; Prenner G; Kniepeiss D; Iberer F; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Leb G; Dobnig H
Wien Klin Wochenschr; 2002 Aug; 114(15-16):717-24. PubMed ID: 12602117
[TBL] [Abstract][Full Text] [Related]
20. [Pediatric renal transplantation: clinical analysis of 23 cases].
Chen JH; Shen W; He Q; Jiang R; Peng WH
Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1100-3. PubMed ID: 15498295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
